Leveraging the unique insights of its founders and an internal team of outstanding scientists, the Company seeks to become an industry leader in the neural stem cell field with multiple
therapeutic product candidates ranging from epilepsy and neuropathic pain to other potential opportunities in the broader neurodegenerative and neuropsychiatric disease space.
The company seeks to become an industry leader in the neural stem cell field with multiple
therapeutic product candidates.
Not exact matches
Non-exclusive licenses are available for research and sale of
products and services across multiple fields including: research tools, kits, reagents; discovery of novel targets for
therapeutic intervention; cell lines for discovery and screening of novel drug
candidates; GMP production of healthcare
products; production of industrial materials such as enzymes, biofuels and chemicals; and synthetic biology.
We leverage our cutting - edge platforms to produce
product candidates and utilize distinct
therapeutic approaches that, we believe, address the shortcomings of existing therapies and have the potential to treat a broad patient population either as individual therapies or in combination with other mechanisms of action.
Its
products includes of drug
candidates of
therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology.